Omeros Shares Fall 15% After CHMP Upholds Negative Drug Opinion
Omeros shares fell 15% on Friday after an EMA committee upheld a negative opinion on its drug for a serious post-transplant condition. H.C. Wainwright called the selloff overdone.
Shares of Omeros Corp (OMER) slumped 15% on Friday after a European Medicines Agency committee upheld a negative opinion on its drug for a serious post-transplant condition, though H.C. Wainwright dismissed the selloff as overdone.The stock is now on track for its steepest one-day decline since lat…